NCT05753800 is a NA clinical trial of INTORUS in Cerebral Palsy, sponsored by University of Extremadura.

Who is sponsoring NCT05753800?

NCT05753800 is sponsored by University of Extremadura.

What drugs are being tested in NCT05753800?

Interventions in NCT05753800: INTORUS.

What condition does NCT05753800 study?

NCT05753800 studies Cerebral Palsy, Motor Disorders, Motor Activity.

Is NCT05753800 still recruiting?

NCT05753800 is currently completed. Last updated 1 December 2023.

Last reviewed 2023-12-01 · How we verify

NCT05753800

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of INTORUS as a Therapeutic Tool in Motor Intervention in Patients at Aspace Centres in the Province of Cáceres

Completed NA Last updated 1 December 2023

What this trial tests

NA trial testing INTORUS in Cerebral Palsy in 50 participants. Completed in 31 August 2023.

Timeline

1 January 2023

Primary endpoint
30 June 2023

31 August 2023

Quick facts

Lead sponsor	University of Extremadura
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	50
Start date	1 January 2023
Primary completion	30 June 2023
Estimated completion	31 August 2023
Sites	1 location across Spain

Drugs / interventions tested

INTORUS

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →
Motor Disorders — all drugs for Motor Disorders →
Motor Activity — all drugs for Motor Activity →

Sponsor

University of Extremadura

Who can join

Adults 4 to 18, any sex, with Cerebral Palsy or Motor Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this Clinical Trial is to verify the effectiveness of the use of the Intorus device in the motor intervention in patients with cerebral palsy and related syndromes. The main question it aims to answer is: Does the use of the Intorus tool manage to improve the mobility of upper limbs (MMSS) in patients with infantile cerebral palsy to increase their performance in activities of daily living? A total of approximately 50 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the motor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the motor level with the INTORUS device. Randomization will be carried out using the Oxford Minimization and Randomization software.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of INTORUS

Trials testing the same drug.

NCT05778994 — Use of Intorus to Control Anxiety Before Exams in Students at the University of Extremadura · NA · completed
NCT05740046 — Motor Intervention Whit the Intorus Tool on Children With Down Syndrome · NA · completed

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other University of Extremadura trials

Trials by the same sponsor.

NCT07292311 — Reliability of Muscle Strength and Activation Assessment Tools and Effects of an Online Therapeutic Exercise Program in · NA · active not recruiting
NCT07408986 — Reference Values and Reliability of Handgrip Strength Assessment Using a Digital Dynamometer in Healthy Adolescents and · completed
NCT07427329 — Benefits of Physical Activity During the School Day to Reduce Mental Fatigue and Optimize Cognitive and Psychosocial Pro · NA · active not recruiting
NCT06953401 — Muscle Activity of the Gastrocnemius and Soleus Muscles by Surface Electromyography. · not yet recruiting
NCT06976593 — Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05753800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Extremadura
Last refreshed: 1 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05753800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing